NO20073440L - Prosess for fremstilling av candesartan - Google Patents

Prosess for fremstilling av candesartan

Info

Publication number
NO20073440L
NO20073440L NO20073440A NO20073440A NO20073440L NO 20073440 L NO20073440 L NO 20073440L NO 20073440 A NO20073440 A NO 20073440A NO 20073440 A NO20073440 A NO 20073440A NO 20073440 L NO20073440 L NO 20073440L
Authority
NO
Norway
Prior art keywords
candesartan
making
preparation
processes
novel
Prior art date
Application number
NO20073440A
Other languages
English (en)
Inventor
Yaping Wang
Yonggang Li
Yulin Li
Guojun Zheng
Yi Li
Stefan Kocher
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of NO20073440L publication Critical patent/NO20073440L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/10—Formation of amino groups in compounds containing carboxyl groups with simultaneously increasing the number of carbon atoms in the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen gjelder nye fremgangsmåter for fremstilling av kandesartan eller en beskyttet form av kandesartan, et kandesartansalt eller en kandesartanester, forbindelser som kan anvendes i fremgangsmåter ifølge oppflnnelsen, fremgangsmåter for deres fremstilling, deres anvendelser i fremgangsmåter ifølge oppflnnelsen, en ny polymorf form av kandesartancilexetil, en fremgangsmåte for deres fremstilling og dens anvendelse for fremstilling av et legemiddel.
NO20073440A 2004-12-16 2007-07-03 Prosess for fremstilling av candesartan NO20073440L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004060699A DE102004060699A1 (de) 2004-12-16 2004-12-16 Verfahren zur Herstellung von Candesartan
PCT/DE2005/002267 WO2006063578A2 (de) 2004-12-16 2005-12-15 Verfahren zur herstellung von candesartan

Publications (1)

Publication Number Publication Date
NO20073440L true NO20073440L (no) 2007-07-03

Family

ID=36168493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073440A NO20073440L (no) 2004-12-16 2007-07-03 Prosess for fremstilling av candesartan

Country Status (12)

Country Link
US (1) US20080114045A1 (no)
EP (1) EP1838699B1 (no)
CN (1) CN101068807A (no)
AT (1) ATE466010T1 (no)
CA (1) CA2587501A1 (no)
DE (2) DE102004060699A1 (no)
ES (1) ES2344571T3 (no)
IL (1) IL183104A0 (no)
NO (1) NO20073440L (no)
PT (1) PT1838699E (no)
RU (1) RU2407741C2 (no)
WO (1) WO2006063578A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2264641B1 (es) * 2005-06-17 2008-03-01 Quimica Sintetica, S.A. Procedimiento para la obtencion de derivados de bencimidazol y sus intermedios.
CN101323610B (zh) * 2007-06-15 2013-10-30 横店集团成都分子实验室有限公司 三苯甲基坎地沙坦酯中间体制备方法
CN101633656B (zh) * 2009-09-08 2013-06-26 江苏德峰药业有限公司 沙坦类药物坎地沙坦的合成方法
CN101781286B (zh) * 2010-01-28 2013-07-10 青岛黄海制药有限责任公司 一种制备坎地沙坦酯的方法
CN101880241B (zh) * 2010-07-14 2013-04-17 浙江美诺华药物化学有限公司 一锅法制备2-(取代苯基)甲氨基-3-硝基苯甲酸甲酯的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
ATE250043T1 (de) * 1991-11-18 2003-10-15 Du Pont Tetrazolylphenylborsäureintermediate zur synthese von aii rezeptor antagonisten
EA000622B1 (ru) * 1995-06-07 1999-12-29 Американ Хоум Продактс Корпорейшн Способ получения производных дифенила
US6177587B1 (en) * 1997-05-26 2001-01-23 Takeda Chemical Industries, Ltd. Production method of aminobenzene compound
US6590100B2 (en) * 2000-03-08 2003-07-08 Rhodia Chimie Process for preparing a polyaromatic compound
CN1207287C (zh) * 2002-12-23 2005-06-22 重庆圣华曦药业有限公司 苯并咪唑的酯类化合物及其制备方法和在制备药用化合物坎地沙坦酯中的应用
WO2004065383A2 (en) * 2003-01-16 2004-08-05 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
US7504516B2 (en) * 2003-03-27 2009-03-17 Hetero Drugs Limited Crystalline forms of candesartan cilexetil
ITMI20032338A1 (it) * 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph Composti feniltetrazolici.

Also Published As

Publication number Publication date
EP1838699A2 (de) 2007-10-03
ES2344571T3 (es) 2010-08-31
RU2407741C2 (ru) 2010-12-27
DE102004060699A1 (de) 2006-06-22
EP1838699B1 (de) 2010-04-28
RU2007125799A (ru) 2009-01-27
DE502005009501D1 (de) 2010-06-10
CN101068807A (zh) 2007-11-07
US20080114045A1 (en) 2008-05-15
WO2006063578A3 (de) 2006-10-12
WO2006063578A2 (de) 2006-06-22
IL183104A0 (en) 2007-09-20
CA2587501A1 (en) 2006-06-22
PT1838699E (pt) 2010-07-07
ATE466010T1 (de) 2010-05-15

Similar Documents

Publication Publication Date Title
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
JO2734B1 (en) Organic compounds
MY146623A (en) Substituted prolinamides, manufacturing, and the use thereof as medicaments
MY153941A (en) Compounds as bradykinin b1 antagonists
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
NO20073440L (no) Prosess for fremstilling av candesartan
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EA201300647A1 (ru) Оптимизированный синтез чистых неполиморфных кристаллических жёлчных кислот с заданным размером частиц
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
MX2010006218A (es) Compuestos organicos.
ATE518853T1 (de) Verbindungen zur behandlung entzündlicher erkrankungen
WO2007147480A3 (en) Polymorphic forms and process
WO2008010764A3 (en) A process for the preparation of substituted 2-acetylamino-alkoxyphenyl

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application